top of page
News, Events and Updates
Search
Anavex Appoints David Tousley as CFO
Sep 29, 2010
ANAVEX 2-73: Journal of Psychopharmacology Publishes Anti-Amnesic and Neuroprotective Data
Sep 12, 2010
Neuroprotective efficacy of ANAVEX 2-73, a novel tetrahydrofuran derivative targeting the sigma-1...
Sep 10, 2010
Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/σ1 ligand ANAVEX 2-73
Sep 8, 2010
Anavex to Present at Rodman & Renshaw Healthcare Conference September 13 in New York City
Sep 7, 2010
Dr. Cameron Durrant Named One of PharmaVOICE’s 100 Most Inspiring in the Pharmaceutical Industry
Aug 29, 2010
Anavex Appoints Contract Research Organizations to Initiate Phase I/IIa Clinical Programs
Aug 9, 2010
Anavex Reports Animal Study Results as Lead Alzheimer’s Compound Approaches Phase 1 Clinical Trials
May 3, 2010
Anavex Comments on Failure of Pfizer and Medivation’s Dimebon
Mar 3, 2010
47
48
49
50
51
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
